FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $904,360 | -40.5% | 426,585 | +33.5% | 0.01% | -33.3% |
| Q2 2023 | $1,520,758 | -18.0% | 319,487 | -1.8% | 0.01% | -25.0% |
| Q1 2023 | $1,854,558 | -42.6% | 325,361 | +1.6% | 0.01% | -42.9% |
| Q4 2022 | $3,232,029 | -51.6% | 320,320 | +7.4% | 0.02% | -54.3% |
| Q3 2022 | $6,684,000 | -10.3% | 298,278 | -0.8% | 0.05% | -6.1% |
| Q2 2022 | $7,450,000 | -30.2% | 300,652 | +9.2% | 0.05% | -15.5% |
| Q1 2022 | $10,679,000 | -33.6% | 275,445 | +0.2% | 0.06% | -31.8% |
| Q4 2021 | $16,080,000 | +2.2% | 274,829 | +3.6% | 0.08% | +1.2% |
| Q3 2021 | $15,729,000 | -21.9% | 265,373 | +14.4% | 0.08% | -22.2% |
| Q2 2021 | $20,127,000 | +50.1% | 231,900 | +42.6% | 0.11% | +44.0% |
| Q1 2021 | $13,406,000 | +18781.7% | 162,596 | +2491.2% | 0.08% | – |
| Q2 2018 | $71,000 | -35.5% | 6,275 | -44.2% | 0.00% | – |
| Q1 2018 | $110,000 | -23.1% | 11,239 | -52.1% | 0.00% | -100.0% |
| Q4 2017 | $143,000 | +53.8% | 23,463 | -0.1% | 0.00% | – |
| Q3 2017 | $93,000 | -3.1% | 23,495 | -20.4% | 0.00% | – |
| Q2 2017 | $96,000 | -28.4% | 29,510 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $134,000 | +81.1% | 29,510 | 0.0% | 0.00% | – |
| Q4 2016 | $74,000 | -19.6% | 29,510 | 0.0% | 0.00% | – |
| Q3 2016 | $92,000 | – | 29,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |